Biobamate

Biobamate Brand names, Biobamate Analogs

Biobamate Brand Names Mixture

No information avaliable

Biobamate Chemical_Formula

C₂₀H₂₃NS

Biobamate RX_link

No information avaliable

Biobamate fda sheet

Biobamate msds (material safety sheet)

Biobamate Synthesis Reference

No information avaliable

Biobamate Molecular Weight

309.469 g/mol

Biobamate Melting Point

< 25 ^oC

Biobamate H₂O Solubility

Soluble as HCl salt

Biobamate State

Liquid

Biobamate LogP

5.7

Biobamate Dosage Forms

Tablets (oral, 1 mg)

Biobamate Indication

Used for the symptomatic treatment of parkinsonism.

Biobamate Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Biobamate Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Biobamate side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Biobamate Patient Information

Biobamate Organisms Affected

Humans and other mammals